• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

AABB and the CDC Outline Guidelines for Laboratory Testing of Patients with Suspected Ebola

September 12, 2014

t_news_12_sept_2014While the Ebola outbreak continues to plague West Africa, there is concern from hospitals in developed nations about handling potentially infected laboratory specimens. The AABB Clinical Transfusion Committee recently posted a document urging healthcare personnel to follow CDC guidelines and to use additional precautions as needed when handling suspected Ebola samples.

To minimize healthcare worker exposure to suspected Ebola infected samples, some medical institutions have recommended skipping pre-transfusion testing and to use group O RBCs for transfusion of suspected Ebola patients instead. This approach, however, could potentially expose patients with alloantibodies to an unnecessary risk for transfusion reactions, especially since alternative diagnoses such as malaria and dengue are more likely to infect travelers from sub-Saharan Africa. Also noteworthy for the transfusion community, transfusion-transmitted Ebola virus has not been documented and is unlikely to occur with current blood screening guidelines. The AABB and the CDC urge all healthcare workers to frequently access the CDC Ebola web page for updates.
References

1. AABB. http://www.aabb.org/press/Pages/Infection-Control-for-Handling-Blood-Specimens-from-Suspected-Ebola-Patients.aspx. Accessed 9 September 2014.
2. CDC. http://www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html. Accessed 9 September 2014.

Filed Under

  • News
  • Quality Control and Regulatory
  • Special Transfusion Situations
  • Transfusion Transmitted Infections

Recommended

  • Time Constraints Deter Blood Donors

  • Reducing the risk of transfusion transmitted Babesia: an AABB Report

  • VIDEO: The Threat of Transfusion-Transmitted Dengue

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley